Sign in
ORGO Stock Price, Chart, Stats & News
Organogenesis Holdings Inc.
Save
310.11M
Market cap
–
Current P/E
12.67x
Forward P/E
ORGO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 74.37% |
Operating margin | 8.27% |
Pretax margin | 8.47% |
Net margin | 6.57% |
Effective tax rate | 22.50% |
ROA | 6.19% |
ROE | 9.56% |
D/E | 0.31x |
Interest coverage ratio | 71.63x |
ORGO valuation
P/E | – |
P/S | 0.52x |
P/B | 0.67x |
P/CF | -28.19x |
P/FCF | -12.04x |
P/OCF | -28.19x |
PEG | 0.04x |
EV multiple | 3.30x |
About
Organogenesis Holdings Inc. is a U. S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products.
Similar securities
Based on sector and market capitalization
Report issue